The present study investigated the anti-proliferative and chemosensitizing effects of var. against multi-drug resistant (MDR) cancer cells. The 80% methanol extract, chloroform (CHCI) fraction and butanol (BuOH) fraction of inhibited the growth of mitoxantrone (MX) resistant HL-60 (HL-60/MX2) cells. When HL-60/MX2 cells were treated with the CHCI and BuOH fractions, DNA ladder and sub-G1 hypodiploid cells were observed. Furthermore, the fractions reduced Bcl-2 mRNA levels, whereas Bax mRNA levels were increased. These results suggest that the inhibitory effect of on the growth of the HL-60/MX2 cells might arise from the induction of apoptosis. Treatment of HL-60/MX2 cells with the fractions markedly decreased the mRNA levels of the multi-drug resistance protein-1 and breast cancer resistance protein. The CHCI3 fraction and hexane fraction increased MX accumulation in HL-60/MX2 cells. These results imply that the CHCI fraction of plays a pivotal role as a chemosensitizer. We suggest that components of might have a therapeutic potential for the treatment of MDR leukemia.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006299 | PMC |
http://dx.doi.org/10.5487/TR.2008.24.1.029 | DOI Listing |
Molecules
July 2023
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
MSN8C, an analog of mansonone E, has been identified as a novel catalytic inhibitor of human DNA topoisomerase II that induces tumor regression and differs from VP-16(etoposide). Treatment with MSN8C showed significant antiproliferative activity against eleven human tumor cell lines in vitro. It was particularly effective against the HL-60/MX2 cell line, which is resistant to Topo II poisons.
View Article and Find Full Text PDFMolecules
August 2022
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Topo II and Hsp90 are promising targets. In this study, we first verified the structural similarities between Topo IIα ATPase and Hsp90α N-ATPase. Subsequently, 720 compounds from the Food and Drug Administration (FDA) drug library and kinase library were screened using the malachite green phosphate combination with the Topo II-mediated DNA relaxation and MTT assays.
View Article and Find Full Text PDFJ Oleo Sci
June 2022
Biochemistry graduate, Department of Biology, Faculty of Basic Sciences, Islamic Azad University Science and Research Branch.
In this study, some phenolic compounds including 4-Hexylresorcinol, 5-Pentadecylresorcinol, 5-Tricosylresorcinol, Bilobol, and Urushiol were tested against α-glycosidase enzyme from Saccharomyces cerevisiae and sorbitol dehydrogenase enzymes from sheep liver. These compounds determined good inhibition properties against α-glycosidase and sorbitol dehydrogenase (SDH) enzymes. IC values were record in the range of 1.
View Article and Find Full Text PDFBioorg Chem
September 2021
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China; Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Guangzhou 510120, People's Republic of China. Electronic address:
Novel mansonone F derivative MSN54 (9-bromo-2,3-diethylbenzo[de]chromene-7,8-dione) exhibited significant cytotoxicity against twelve human tumor cell lines in vitro, with particularly strong potency against HL-60/MX2 cell line resistant to Topo II poisons. MSN54 was found to have IC of 0.69 and 1.
View Article and Find Full Text PDFMolecules
September 2020
Chair and Department of Drug Chemistry, Medical University, Jaczewskiego 4 Street, 20-090 Lublin, Poland.
The aim of this study was to evaluate the ability of multivariate techniques to predict antioxidant and cytotoxic activity of the selected lichens from the chromatographic data. A simple and reproducible HPLC-DAD technique has been used to obtain the chromatographic fingerprint profiles. Reversed phase high performance liquid chromatography (RP-HPLC) linear gradient system with methanol, water and phosphoric acid (V) (pH 2.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!